about
The Interaction Between Statins and Exercise: Mechanisms and Strategies to Counter the Musculoskeletal Side Effects of This Combination TherapyEfficacy and safety of alirocumab in patients with hypercholesterolemia not adequately controlled with non-statin lipid-lowering therapy or the lowest strength of statin: ODYSSEY NIPPON study design and rationale.Comparison between Atorvastatin and Rosuvastatin in Renal Function Decline among Patients with DiabetesRocuronium blockade reversal with sugammadex vs. neostigmine: randomized study in Chinese and Caucasian subjects.Statin therapy and hepatotoxicity: Appraisal of the safety profile of atorvastatin in hyperlipidemic patients.Effect of different loading doses of atorvastatin on percutaneous coronary intervention for acute coronary syndromes.A retrospective study on the efficacy of a ten-milligram dosage of atorvastatin for treatment of hypercholesterolemia in type 2 diabetes mellitus patients.Rhabdomyolysis with simvastatin.Cost-effectiveness of high, moderate and low-dose statins in the prevention of vascular events in the Brazilian public health system.Dyslipidemia in special ethnic populationsIndividualized risk for statin-induced myopathy: current knowledge, emerging challenges and potential solutionsStatin Safety in Chinese: A Population-Based Study of Older AdultsNational Assessment of Statin Therapy in Patients Hospitalized with Acute Myocardial Infarction: Insight from China PEACE-Retrospective AMI Study, 2001, 2006, 2011Efficacy study of olmesartan medoxomil on coronary atherosclerosis progression and epicardial adipose tissue volume reduction in patients with coronary atherosclerosis detected by coronary computed tomography angiography: study protocol for a randomA Randomized Trial Assessing the Effectiveness of Ezetimibe in South Asian Canadians with Coronary Artery Disease or Diabetes: The INFINITY Study.Blood Lipid Concentrations and Colorectal Adenomas: A Systematic Review and Meta-Analysis of Colonoscopy Studies in Asia, 2000-2014.Assessment of statin-associated muscle toxicity in Japan: a cohort study conducted using claims database and laboratory information.Phase I, multicenter, open-label, dose-escalation study of sonidegib in Asian patients with advanced solid tumorsEffect of fixed-dose combinations of ezetimibe plus rosuvastatin in patients with primary hypercholesterolemia: MRS-ROZE (Multicenter Randomized Study of ROsuvastatin and eZEtimibe).Diabetogenic effect of statins: a double-edged sword?Effects of statin treatment in patients with coronary artery disease and chronic kidney diseaseCharacterization of ADME gene variation in 21 populations by exome sequencing.Efficacy of low- and moderate-intensity statins for achieving low- density lipoprotein cholesterol targets in Thai type 2 diabetic patients.Non-adherence to statin therapy: a major challenge for preventive cardiology.Efficacy of Moderate Intensity Statins in the Treatment of Dyslipidemia in Korean Patients with Type 2 Diabetes Mellitus.Reduction in cardiovascular risk using a proactive multifactorial intervention is consistent among patients residing in Pacific Asian and non-Pacific Asian regions: a CRUCIAL trial subanalysis.Comparison of low-dose rosuvastatin with atorvastatin in lipid-lowering efficacy and safety in a high-risk pakistani cohort: an open-label randomized trialManagement of cholesterol to reduce the burden of stroke in Asia: consensus statement.Pharmacogenetics of nonsteroidal anti-inflammatory drugs.Do statins cause diabetes?A review of statin use in patients with acute coronary syndrome in Western and Japanese populations.What the guidelines do not say: statin non-benefit groups.Challenges in application of bioanalytical method on different populations and effect of population on PK.Statin intolerance: diagnosis and remedies.Patterns of statin non-prescription in patients with established coronary artery disease: A report from a contemporary multicenter Japanese PCI registryStatin-related aminotransferase elevation according to baseline aminotransferases level in real practice in Korea.Analysis and comparison of the cost-effectiveness of statins according to the baseline low-density lipoprotein cholesterol level in Korea.Use of Moderate-Intensity Statins for Low-Density Lipoprotein Cholesterol Level above 190 mg/dL at Baseline in Koreans.Effects of Different Types of Statins on Lipid Profile: A Perspective on Asians.Letter: a retrospective study on the efficacy of a ten-milligram dosage of atorvastatin for treatment of hypercholesterolemia in type 2 diabetes mellitus patients (korean diabetes j 2010;34:359-67).
P2860
Q26771168-67959A07-AF9B-4721-A70F-9DD6BBA4CF81Q33808620-00C2104B-3024-46B1-A1EC-D98968F9BA4CQ33889894-FAE77C00-694C-4D26-9612-2083979BB816Q34125680-3279A8C0-1FDB-41CB-AACF-2C33DF9CF148Q34169932-E129F8AE-3BE4-46D6-8BCE-6393A50D5DE5Q34338642-B109D324-2784-4108-BC11-3444BD0B227FQ34491061-964A38A0-2B3D-4585-A0AC-F88F2671C9E2Q34526546-CE381D26-9394-4338-8788-1ADA7050F177Q35292482-AF0A2212-E657-495C-BD39-F5A1A2B4F6A0Q35573543-63B58182-4005-478D-ABCB-FF57E084E5B7Q35915932-C23A4522-46E1-45BF-94EC-219E9E729F13Q35949456-523BCB22-B44A-4C21-86FD-F20E629289DFQ35983833-C8F9A239-3A64-4257-A758-0C44AB4AFAA6Q36433276-271EB442-0AD6-41E8-AEE1-362ADBEC16FDQ36486376-FB832032-38FB-4543-9609-F788FB319BC9Q36799140-1DE547EA-0CC3-403A-B5C8-7AB557E5DC7EQ36809811-802FF4D8-977C-49C1-97A3-1230AB06F71BQ37375259-6C12F1E1-5280-4F9F-B71F-34C1DB2941CDQ37412866-80611B7A-4FF6-429D-BA17-B38673E30A13Q37435688-5BDE4564-E4CF-4475-AFC0-1D6E79ACDB5BQ37471756-9726DFAB-F72C-452C-A974-F2C60543E1E6Q37619264-373EE44E-F27F-4DFE-A13D-07E096178197Q37640762-0670F7DA-63DD-471B-B99F-6068E7FD8CBAQ37642755-65CEC46F-F319-4033-BB45-B1DB63A0D8DDQ37670093-9E3B3CB2-D823-4EC2-9778-5CF2408C540DQ37677986-ACC145EF-5DE9-41B6-8E44-27DDD53288EBQ37700760-E56C7FE7-58A1-442B-96BF-7D18EC9DAA42Q37764011-3DC1C401-E157-4430-B96F-30F3408BDFC2Q38050316-A4A3072A-89C1-4BBF-BC02-48A7264C8798Q38086101-FA028610-1086-4892-BE26-FD936A8D1046Q38097397-A717F6C2-AF91-4F1C-A31B-6B391DA8C3BAQ38268914-478D9FD3-4D94-4DAF-972A-D5A72839824AQ38296214-B18BE029-D3F2-4075-BFBA-266A28B94B77Q38430744-21E5376D-44F0-40FB-B14A-B9C4A317BD00Q38640919-430B3FB2-95BD-4926-8CA0-DEA2C7032727Q38890066-C9E7432E-1A07-4719-AB42-46C0E5B3D411Q38934196-19DEBD25-0EBB-462F-808F-EC4E77AB5B22Q38976878-0732651A-FB80-41BD-9E29-68DCFA600454Q41391827-9059280A-B179-4F2A-957E-66C87605615BQ41825015-DDF6DD32-446B-4EAA-AE52-20494BB82515
P2860
description
2006 nî lūn-bûn
@nan
2006 թուականի Դեկտեմբերին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի դեկտեմբերին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Safety and efficacy of statins in Asians.
@ast
Safety and efficacy of statins in Asians.
@en
Safety and efficacy of statins in Asians.
@nl
type
label
Safety and efficacy of statins in Asians.
@ast
Safety and efficacy of statins in Asians.
@en
Safety and efficacy of statins in Asians.
@nl
prefLabel
Safety and efficacy of statins in Asians.
@ast
Safety and efficacy of statins in Asians.
@en
Safety and efficacy of statins in Asians.
@nl
P2860
P1476
Safety and efficacy of statins in Asians.
@en
P2093
James K Liao
P2860
P304
P356
10.1016/J.AMJCARD.2006.08.051
P407
P577
2006-12-15T00:00:00Z